This is the authors' abstract. We don't add key points for this paper.
Surface-based ultrasound systems have shown a remarkable improvement over the years, both in enhanced image quality, ease-of-use, and reduction in overall system size. Their ability to image organs non-invasively make them a prime technology for the diagnosis and monitoring of various diseases and conditions. One such potential use case is the screening of prostate cancer using prostate-specific antigen density (combining prostate-specific antigen values with prostate volumes). Current literature predominantly focuses on prostate volume estimation techniques that make use of magnetic resonance- or transrectal ultrasound-imaging, while surface-based techniques are largely skipped over. If a reliable surface-based ultrasound prostate cancer screening method can be introduced, a portion of patients may be able to forgo unnecessary magnetic resonance- or transrectal ultrasound-scans. This would save healthcare systems both time and resources as such a screening procedure could potentially be introduced into standard primary care settings with portable point-of-care ultrasound systems available at a fraction of the cost of their larger hospital counterparts. This review considers whether published literature suggests it is possible to use surface-based ultrasound devices in the calculation of prostate volume with high enough efficacy to be used in prostate cancer screening in primary health care, prior to secondary referral.
No takes yet. Share an insight, caveat, or question.
Bennett et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: